Bayer Shareholders Face Pivotal Vote Amid Mounting Legal Liabilities

Bayer proposes a steady 0.11 euro dividend for 2025 at its virtual AGM, despite forecasting negative free cash flow in 2026 due to ~5B euro legal provisions.

Investors in Bayer are marking their calendars for April 24, 2026. On that date, a virtual Annual General Meeting will convene, with a crucial dividend proposal for the 2025 fiscal year topping the agenda. This vote comes as the company navigates a complex landscape, striving for operational stability while contending with legal costs that threaten to burden its financial performance for years to come.

Electronic AGM and Dividend Proposal

The company has proposed maintaining its dividend at the previous year's level of 0.11 euros per share for 2025. Should shareholders approve the measure, the payment is scheduled for April 29. The ex-dividend date is set for either April 27 or 28.

Participation in the virtual meeting is exclusively electronic. Shareholders wishing to submit countermotions or electoral proposals face a tight deadline, with the cut-off set for April 9. Final registration for the meeting must be completed by April 17.

A Challenging 2026 Outlook

Behind the steady dividend plan lies a difficult forecast for 2026. Management is targeting currency-adjusted sales between 45 and 47 billion euros. However, the company anticipates a negative free cash flow for the year, signaling constrained financial flexibility.

The primary driver of this pressure is a massive financial burden from ongoing litigation. Bayer has provisioned for legal payouts totaling approximately 5 billion euros in 2026. This substantial sum will significantly impact the bottom line, even as the company projects a still-solid adjusted EBITDA ranging from 9.6 to 10.1 billion euros.

Market Performance and Technical Position

The market has reacted cautiously to these strategic and financial headwinds. Bayer shares are currently trading at USD 11.45, a level roughly 20% below their 52-week high reached in February. With a Relative Strength Index (RSI) reading of 45.4, the stock resides in neutral territory but is currently struggling to reclaim its 50-day moving average of USD 12.17.

The upcoming AGM will serve as a key indicator of shareholder confidence in the board's strategy for managing these extensive legal risks. The final registration phase runs until April 17, following the April 9 deadline for proposals. The voting results on April 24 will ultimately provide clarity on the future direction of the company's dividend policy.